Highnoon Laboratories Limited (HINOON)

PHARMACEUTICALSALLSHRKMIALLSHRKSE100KSE100PR

970.39

-0.49%

As of 25-Aug-2026

52 Week RangeCurrent: 970.39

755.561237.99

Updated: 25-Aug-2026

1M+1.0%

3M+0.2%

1Y-17.0%

3Y+191.5%

5Y+147.0%

Valuation Snapshot

Review how the market has valued this company across price multiples.

Updated through 21-Aug-2026

P/E

12.58x

P/B

3.70x

P/S

2.01x

EV/Sales

7.17x

EV/EBITDA

24.97x

Showing 37 observations

Annual Ratio Highlights

Metric	2021	2022	2023	2024	2025
EPS	34.12	45.62	45.35	61.41	77.75
DPS	14.37	15.81	30.01	40.01	50.00
BVPS	108.78	140.52	181.14	211.80	248.58
PER	28.94x	21.64x	21.77x	16.08x	12.70x
Div Yield	1.46%	1.60%	3.04%	4.05%	5.06%
PBV	9.08	7.03	5.45	4.66	3.97
EV/Sales	3.83x	3.25x	2.64x	2.09x	1.91x
Price/Sales	4.02x	3.31x	2.69x	2.26x	2.03x
EV/EBITDA	18.87x	14.22x	13.37x	8.61x	6.88x
EV/Gross Profit	7.76x	6.41x	5.55x	4.07x	3.49x

Metric	2021	2022	2023	2024	2025
Gross Margin	49.35%	50.77%	47.64%	51.43%	54.78%
EBITDA Margin	20.30%	22.87%	19.77%	24.30%	27.76%
Operating Margin	18.98%	21.67%	18.51%	22.96%	26.31%
Pretax Margin	18.24%	21.16%	17.00%	20.86%	25.53%
Net Margin	13.91%	15.28%	12.37%	14.03%	15.97%

Metric	2021	2022	2023	2024	2025
ROE	35.28%	36.60%	28.20%	31.26%	33.77%
ROA	24.46%	25.72%	19.48%	21.63%	23.90%
ROTA	33.38%	36.47%	29.15%	35.40%	39.37%
ROCE	38.33%	41.92%	32.24%	43.58%	48.81%